IPP Bureau
Prataprao Ganpatrao Jadhav takes charge as Minister of State in the Ministry of Health & Family Welfare
By IPP Bureau - June 11, 2024
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
Fischer Medical Venture and BluSim Tech partner to redefine elderly care
By IPP Bureau - June 10, 2024
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
Neuland unveils refreshed brand identity
By IPP Bureau - June 10, 2024
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
By IPP Bureau - June 09, 2024
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis
By IPP Bureau - June 09, 2024
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Syntegon acquires Telstar
By IPP Bureau - June 09, 2024
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Lilly CFO Anat Ashkenazi resigns
By IPP Bureau - June 09, 2024
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Gavi outlines plans to support access to new vaccines
By IPP Bureau - June 09, 2024
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Borosil Scientific debuts on stock exchange
By IPP Bureau - June 08, 2024
This strategic decision will unlock significant value for our scientific and industrial products business
Sun Pharma to acquire stake in HaystackAnalytics
By IPP Bureau - June 08, 2024
HaystackAnalytics is engaged in the business of developing genomic analysis software
Briefs: Dr. Reddy's Laboratories and Ami Organics
By IPP Bureau - June 08, 2024
Dr. Reddy's Laboratories gets Form 483 from USFDA with 4 observations for API facility
GSK acquires oligonucleotide drug startup Elsie
By IPP Bureau - June 08, 2024
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Briefs: Concord Biotech and Shelter Pharma
By IPP Bureau - June 08, 2024
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Lupin completes acquisition of two brands from Sanofi in Europe and Canada
By IPP Bureau - June 08, 2024
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Indoco Remedies receives tentative ANDA approval for Canagliflozin, Metformin Hydrochloride Tablets
By IPP Bureau - June 07, 2024
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
